Collaboration Agreement, Cash Milestone Payments Received

No definition available.

Name:	bpmc_CollaborationAgreementCashMilestonePaymentsReceived
Namespace Prefix:	bpmc_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Collaboration Agreement, Percentage of Global Development Costs Shared, Counterparty

+ References

No definition available.

+ Details

Name:	bpmc_CollaborationAgreementPercentageOfGlobalDevelopmentCostsSharedCounterparty
Namespace Prefix:	bpmc_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Collaboration Agreement, Percentage of Global Development Costs Shared, Entity

+ References

No definition available.

+ Details

Name:	bpmc_CollaborationAgreementPercentageOfGlobalDevelopmentCostsSharedEntity
Namespace Prefix:	bpmc_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of upfront cash payment receivable under the collaboration agreement.

+ References

No definition available.

+ Details

Name:	bpmc_CollaborationAgreementUpfrontCashPaymentsReceivable
Namespace Prefix:	bpmc_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Represents the aggregate amount of eligible contingent option fees and milestone payments related to specified research, pre-clinical, clinical, regulatory and sales-based milestones.

+ References

No definition available.

+ Details

Name:	bpmc_CollaborativeArrangementEligibleContingentOptionFeesAndMilestonePayments
Namespace Prefix:	bpmc_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Non-refundable upfront payment received by the reporting entity from the collaborative partner.

+ References

No definition available.

+ Details

Name:	bpmc_NonrefundableUpfrontPaymentReceived
Namespace Prefix:	bpmc_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of share proceeds that will be received on issuance of additional shares in private placement under share repurchase agreement.

+ References

No definition available.

+ Details

Name:	bpmc_PrivatePlacementAdditionalShareProceedsToBeReceived
Namespace Prefix:	bpmc_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Number of shares agreed to be issued or sold under the share purchase agreement in private placement.

+ References

No definition available.

+ Details

Name:	bpmc_PrivatePlacementSharesAgreedToBeIssuedOrSold
Namespace Prefix:	bpmc_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585

+ Details

Name:	us-gaap_ProceedsFromIssuanceOfPrivatePlacement
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Price of a single share of a number of saleable stocks of a company.

+ References

No definition available.

+ Details

Name:	us-gaap_SharePrice
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Per share or per unit amount of equity securities issued.

+ References

No definition available.

+ Details

Name:	us-gaap_SharesIssuedPricePerShare
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of new stock issued during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsequentEventLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=bpmc_ClementiaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=bpmc_RocheMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Subsequent Events (Details) - Collaboration - USD ($) $ / shares in Units, $ in Millions			1 Months Ended
	Jul. 13, 2020	Oct. 15, 2019	Jul. 31, 2020	Oct. 31, 2019	Mar. 31, 2016	Sep. 30, 2020
Clementia
Subsequent Events
Non-refundable upfront payment received		$ 25.0
Milestone payment received				$ 20.0
Roche
Subsequent Events
Non-refundable upfront payment received					$ 45.0
Eligible contingent option and milestone payments					$ 940.0
Subsequent Event \| Clementia
Subsequent Events
Milestone payment received			$ 20.0
Subsequent Event \| Roche
Subsequent Events
Upfront cash payment receivable						$ 675.0
Non-refundable upfront payment received	$ 675.0
Eligible contingent option and milestone payments	$ 927.0
Percentage of global development costs, Company (as a percent)	45.00%
Percentage of global development costs, Roche (as a percent)	55.00%
Subsequent Event \| Private Placement \| Roche
Subsequent Events
Purchase price	$ 96.57
Stock purchase agreement issued and sold	973,386
Private placement purchase price	$ 96.57
Gross proceeds from issuance of private placement	$ 94.0
Number of shares agreed to be issued or sold under the share purchase agreement	62,133
Additional gross proceeds to expiration or termination	$ 6.0